<DOC>
<DOCNO>EP-0642796</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Salmonella live vaccines
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3902	A61K3902	A61K39112	A61K39112	A61P3100	A61P3104	C12N120	C12N120	C12N136	C12N136	C12R142	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61P	A61P	C12N	C12N	C12N	C12N	C12R	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K39	A61K39	A61K39	A61K39	A61P31	A61P31	C12N1	C12N1	C12N1	C12N1	C12R1	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The use of at least one attenuated immunogenic salmonella live vaccine strain which is provided with a marker (envelope marker) conferring sensitivity to macrolide antibiotics for the production of a live vaccine for a particular host which, in the case of an infection of another host caused by the first, allows effective therapeutic treatment of the infected host using macrolides.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
LOHMANN ANIMAL HEALTH GMBH
</APPLICANT-NAME>
<APPLICANT-NAME>
LOHMANN ANIMAL HEALTH GMBH 
&
 CO. KG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BEER JOERG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
LINDE KLAUS PROF DR
</INVENTOR-NAME>
<INVENTOR-NAME>
RANDHAGEN BAERBEL DIPL-ING
</INVENTOR-NAME>
<INVENTOR-NAME>
BEER,JOERG DR
</INVENTOR-NAME>
<INVENTOR-NAME>
LINDE,KLAUS PROF DR
</INVENTOR-NAME>
<INVENTOR-NAME>
RANDHAGEN,BAERBEL DIPL-ING
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
